ACCD: Accolade Inc P/S Multiple

Symbol and logo of brand Accolade Health (ACCD)

Accolade operates amid fierce competition for corporate contracts against insurance behemoths. The P/S time series illustrates the business valuation trend, where the value 1.30 describes the current multiplier level. ARR growth and AI assistants are driving B2B expansion, while the development strategy relies on technological integration with insurance companies.

ACCD (Accolade) P/S Multiple history from 07/04/2022 to 04/19/2025

Analytical breakdowns for Accolade (ACCD)

- current price and projected stock value:
Price Chart accolade.com|ACCD - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Accolade Health|ACCD - Enterprise Value
- balance sheet equity data:
Equity per Share Accolade|ACCD - Book Capitalization|Market-to-Book Ratio accolade.com|ACCD - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Accolade|ACCD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio accolade.com|ACCD - Company Aggregate Debts|Debt to Book Value Accolade Health|ACCD - Company Long-Term Debts|Company Short-Term Indebtedness Accolade|Intermediate Liquidity Ratio accolade.com
- net income and valuation multiples indicators:
ACCD - Net Profit|Expected Net Profit Accolade|ACCD - Price to Earnings Ratio|Future Price to Earnings accolade.com|ACCD - PEG Multiple|Company Value to EBITDA Accolade Health|ACCD - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Accolade|ACCD - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months accolade.com|ACCD - Earnings growth in current year|Projected earnings per share growth rate for next year Accolade
- issuer revenue and sales details:
ACCD - Revenue and Sales Volume|Projected Sales Volume accolade.com|ACCD - P/S Multiple|Forward Price-to-Revenue Multiple Accolade Health
General company analysis:ACCD (Accolade Inc)
Signature product of Accolade, Inc.

The P/S multiple determines the market value of each unit of revenue, allowing for an assessment of sales efficiency regardless of current profit. The integration of virtual clinics and the expansion of the Accolade (ACCD) partner network directly impact revenue volume; therefore, the P/S multiple trend helps determine whether the current price is fair or creates a risk of overpayment when investing in equity.

Competing companies

Price-to-Revenue Ratio HIMS (forhims.com)|P/S Multiple HNGE (Hinge Health)|P/S Multiple Teladoc Health TDOC|Talkspace Corp - P/S Multiple|LFMD (LifeMD, Inc.) - Market Cap to Revenue Ratio|AMWL: P/S Multiple|Price to Sales Mangoceuticals (MGRX)|DRIO (DarioHealth) - P/S Multiple|P/S Multiple VSee|P/S Multiple MNDR|Market Cap to Revenue Biotricity Inc BTCY|P/S Multiple LYT (Lytus Technologies)|OTRK - Market Cap to Revenue|SHL Telemedicine, Ltd. - P/S Multiple|THRN (Thorne HealthTech Inc) - Market Cap to Revenue Ratio